China SXT Pharmaceuticals SXTC

$ 0.35 2.65%

Annual report 2024
added 12-21-2024

China SXT Pharmaceuticals Financial Statements 2011-2024 | SXTC

Annual Financial Statements China SXT Pharmaceuticals

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	885 K	1 M	156 K	468 K	407 K	16.9 M	3 M	-	-	-	-	-	-	-
Shares	867 K	6.67 M	1.04 M	720 K	309 K	5.14 M	20 M	-	-	-	-	-	-	-
Historical Prices	1.02	0.15	0.15	0.65	1.32	3.28	-	-	-	-	-	-	-	-
Net Income	-3.1 M	-5.93 M	-5.74 M	-2.75 M	-10.3 M	1.54 M	1.19 M	1.19 M	-	-	-	-	-	-
Revenue	-	-	-	4.78 M	5.16 M	7.01 M	7.02 M	4.88 M	-	-	-	-	-	-
Cost of Revenue	1.37 M	1.55 M	1.35 M	1.94 M	2.46 M	2.4 M	3.62 M	2.57 M	-	-	-	-	-	-
Gross Profit	554 K	426 K	1.25 M	2.84 M	2.7 M	4.61 M	3.4 M	2.31 M	-	-	-	-	-	-
Operating Income	-2.52 M	-5.61 M	-5.19 M	-2.2 M	-1.34 M	1.77 M	1.63 M	1.6 M	-	-	-	-	-	-
Interest Expense	-	477 K	36.7 K	1.62 M	3.35 M	5.17 K	779	40.4 K	-	-	-	-	-	-
EBITDA	-2.31 M	-5.36 M	-4.87 M	-1.85 M	-1.01 M	1.95 M	1.76 M	1.7 M	-	-	-	-	-	-
Operating Expenses	-	-	-	5.04 M	4.04 M	2.84 M	1.77 M	710 K	-	-	-	-	-	-
General and Administrative Expenses	300 K	5.65 M	5.52 M	3.45 M	2.46 M	2.84 M	1.77 M	565 K	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement China SXT Pharmaceuticals

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	2.03 M	-	16.9 M	-	776 K	-	62.1 M	-	8.67 M	-	23.2 M	-	22.7 M	-	-	-	20 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency